Kazia Therapeutics Ltd (NASDAQ:KZIA)

4.60
Delayed Data
As of 10:05am ET
 +0.27 / +6.24%
Today’s Change
1.63
Today|||52-Week Range
7.60
+44.66%
Year-to-Date
Institutional investors purchased a net $375.1 thousand shares of KZIA during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 9.32% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Other institutional9.32%
Mutual fund holders0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2017SABBY CAPITAL LLC  Bought 366.7 Thousand shares of Kazia Therapeutics Ltd
12/31/2017MORGAN STANLEY & CO. LLC  Bought 6.5 Thousand shares of Kazia Therapeutics Ltd
12/31/2017RBC CAPITAL MARKETS LLC (INVESTM...  Bought 1.3 Thousand shares of Kazia Therapeutics Ltd

Top 10 Owners of Kazia Therapeutics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC7.57%366,6681,943,340+366,668--
Morgan Stanley & Co. LLC0.95%46,001243,805+6,501+16.46%
Renaissance Technologies LLC0.71%34,325181,92300.00%
UBS Securities LLC0.06%2,84515,079+1,013+55.29%
RBC Capital Markets LLC (Investme...0.03%1,2506,625+1,250--
UBS Financial Services, Inc.0.00%2081,10200.00%
Bank of America, NA (Private Bank...0.00%00-146-100.00%
Marketocracy Capital Management L...0.00%00-200-100.00%
Merrill Lynch, Pierce, Fenner & S...0.00%527+5--

Top 10 Mutual Funds Holding Kazia Therapeutics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.00%00-200-100.00%